Company Overview - Cofoe Medical Technology Co., Ltd. specializes in the research, production, sales, and service of medical devices, with key products including blood glucose systems, uric acid systems, blood pressure monitors, and various other medical instruments and supplies [2]. Financial Performance - For Q1 2025, the company reported revenue of 738 million yuan, a year-on-year decrease of 8.59%, and a net profit of 91.43 million yuan, down 9.68%, with a gross profit margin of 52.17% [2]. Market Position - As of August 1, Cofoe Medical's stock closed at 38.39 yuan, up 4.09%, with a rolling price-to-earnings (PE) ratio of 26.58, marking a new low in 107 days. The company's total market capitalization is 8.027 billion yuan [1]. - In comparison to the medical device industry, which has an average PE of 53.65 and a median of 37.22, Cofoe Medical ranks 53rd in terms of PE [1][3]. Shareholder Information - As of June 20, 2025, Cofoe Medical has 19,000 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1].
可孚医疗收盘上涨4.09%，滚动市盈率26.58倍，总市值80.27亿元